Company intelligence / Profile preview

Inflammatix

Sunnyvale, California, United Statesinflammatix.com ↗

Ownership: Private
Development stage: Commercial

Overview

Inflammatix’s lead product TriVerity has received FDA Breakthrough Device Designation and recently obtained FDA clearance. The system provides results in about 30 minutes from a blood sample to determine the likelihood of bacterial or viral infection and risk of severe illness in patients with suspected acute infections or sepsis. Clinical studies have demonstrated its ability to improve diagnostic accuracy over standard methods by leveraging immune response signatures analyzed via machine learning.

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: DeviceDiagnostic test (molecular diagnostics using mRNA profiling and machine learning)
Industry: Molecular Diagnostics

Drug pipeline

1 asset

TriVerity

Commercial

Indications: Acute infection, Sepsis

Partnerships

Biomedical Advanced Research and Development Authority (BARDA), U.S. Department of Health & Human ServicesAcademic partnership with Stanford University for biomarker licensingMultiple venture capital investors as strategic partners

Beyond the preview

Go deeper on Inflammatix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatix.

Explore the full profile